Description: Discover ABECMA® (idecabtagene vicleucel), the first CAR T cell therapy for relapsed/refractory multiple myeloma, how it works, how it helps, and see patient stories. See Safety Info and Boxed WARNINGS.
What is ABECMA? ABECMA (idecabtagene vicleucel) is a prescription medicine for the treatment of multiple myeloma in patients who have received at least four kinds of treatment regimens that have not worked or have stopped working. ABECMA is a medicine made from your own white blood cells; the cells are genetically modified to recognize and attack your multiple myeloma cells.
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.